Cargando…

Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study

BACKGROUND: Perioral dermatitis (POD) is a common inflammatory skin disease without standard therapy. OBJECTIVE: We sought to evaluate the clinical value of a soothing fluid for the treatment of POD. METHODS: We included 51 patients with POD in this 8-week clinical trial. The Toleriane Fluide Effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehmann, Laura, Reinholz, Markus, Maier, Tanja, Lang, Martin, Wollenberg, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135100/
https://www.ncbi.nlm.nih.gov/pubmed/25143674
http://dx.doi.org/10.5021/ad.2014.26.4.462
_version_ 1782330937517801472
author Ehmann, Laura
Reinholz, Markus
Maier, Tanja
Lang, Martin
Wollenberg, Andreas
author_facet Ehmann, Laura
Reinholz, Markus
Maier, Tanja
Lang, Martin
Wollenberg, Andreas
author_sort Ehmann, Laura
collection PubMed
description BACKGROUND: Perioral dermatitis (POD) is a common inflammatory skin disease without standard therapy. OBJECTIVE: We sought to evaluate the clinical value of a soothing fluid for the treatment of POD. METHODS: We included 51 patients with POD in this 8-week clinical trial. The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) study had an open-label design and involved twice-daily application of Toleriane Fluide, a soothing cosmetic fluid. Clinical assessment of POD was performed with a predefined questionnaire including the POD severity index (PODSI). Control visits were made after 4 and 8 weeks of treatment. RESULTS: The results were compared with those of a historical control group treated with a vehicle cream. Patients treated with the soothing fluid showed a continuous and significant improvement of the PODSI over time. The improvement of PODSI observed with the soothing fluid was better, but not significantly better, than that observed in the historical controls. In addition, the subjective complaints of patients such as disease burden, itching, distension of the skin, and appearance improved during treatment. CONCLUSION: A soothing fluid could be a clinically useful treatment option for POD.
format Online
Article
Text
id pubmed-4135100
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-41351002014-08-20 Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study Ehmann, Laura Reinholz, Markus Maier, Tanja Lang, Martin Wollenberg, Andreas Ann Dermatol Original Article BACKGROUND: Perioral dermatitis (POD) is a common inflammatory skin disease without standard therapy. OBJECTIVE: We sought to evaluate the clinical value of a soothing fluid for the treatment of POD. METHODS: We included 51 patients with POD in this 8-week clinical trial. The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) study had an open-label design and involved twice-daily application of Toleriane Fluide, a soothing cosmetic fluid. Clinical assessment of POD was performed with a predefined questionnaire including the POD severity index (PODSI). Control visits were made after 4 and 8 weeks of treatment. RESULTS: The results were compared with those of a historical control group treated with a vehicle cream. Patients treated with the soothing fluid showed a continuous and significant improvement of the PODSI over time. The improvement of PODSI observed with the soothing fluid was better, but not significantly better, than that observed in the historical controls. In addition, the subjective complaints of patients such as disease burden, itching, distension of the skin, and appearance improved during treatment. CONCLUSION: A soothing fluid could be a clinically useful treatment option for POD. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2014-08 2014-07-31 /pmc/articles/PMC4135100/ /pubmed/25143674 http://dx.doi.org/10.5021/ad.2014.26.4.462 Text en Copyright © 2014 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ehmann, Laura
Reinholz, Markus
Maier, Tanja
Lang, Martin
Wollenberg, Andreas
Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
title Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
title_full Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
title_fullStr Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
title_full_unstemmed Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
title_short Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
title_sort efficacy and safety results of a drug-free cosmetic fluid for perioral dermatitis: the toleriane fluide efficacy in perioral dermatitis (tolpod) study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135100/
https://www.ncbi.nlm.nih.gov/pubmed/25143674
http://dx.doi.org/10.5021/ad.2014.26.4.462
work_keys_str_mv AT ehmannlaura efficacyandsafetyresultsofadrugfreecosmeticfluidforperioraldermatitisthetolerianefluideefficacyinperioraldermatitistolpodstudy
AT reinholzmarkus efficacyandsafetyresultsofadrugfreecosmeticfluidforperioraldermatitisthetolerianefluideefficacyinperioraldermatitistolpodstudy
AT maiertanja efficacyandsafetyresultsofadrugfreecosmeticfluidforperioraldermatitisthetolerianefluideefficacyinperioraldermatitistolpodstudy
AT langmartin efficacyandsafetyresultsofadrugfreecosmeticfluidforperioraldermatitisthetolerianefluideefficacyinperioraldermatitistolpodstudy
AT wollenbergandreas efficacyandsafetyresultsofadrugfreecosmeticfluidforperioraldermatitisthetolerianefluideefficacyinperioraldermatitistolpodstudy